JUMPCAN(SH:600566) Xin Lang Cai Jing·2025-11-13 03:17Core Insights - The stock price of Jichuan Pharmaceutical has decreased by 2.00% as of November 13, trading at 27.43 CNY per share with a total market capitalization of 25.254 billion CNY [1] - The company has experienced a significant decline in revenue and net profit for the first nine months of 2025, with revenue down 32.27% year-on-year and net profit down 46.27% [2] Financial Performance - For the period from January to September 2025, Jichuan Pharmaceutical reported a revenue of 3.932 billion CNY and a net profit attributable to shareholders of 1.022 billion CNY [2] - The company has distributed a total of 9.227 billion CNY in dividends since its A-share listing, with 3.931 billion CNY distributed over the last three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 47,400, while the average number of circulating shares per person decreased by 7.02% to 19,370 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 500 ETF, with notable reductions in their holdings [3]